New Aspects for Treatment with Fosfomycin

Fosfomycin, the first representative of a completely new class of antibiotics does not show cross-resistance with other antibiotics; Clinical investigations show a favorable therapeutic outcome in severe nosocomial infections despite of previous therapeutic approaches with various other potent antibiotics.